The findings of the current global metabolomics analysis of plasma and spot urine samples from diabetic WT and meprin βKO mice offer insights into the metabolic alterations occurring in diabetes and the role that meprin β plays in modulating diabetic kidney injury and other complications of diabetes. This evidence concerns the gene MEP1B and diabetes mellitus.